[HTML][HTML] Protective role of taurine against oxidative stress
S Baliou, M Adamaki, P Ioannou… - Molecular …, 2021 - build.spandidos-publications.com
… without increasing hepatic fatty acid synthesis (224). Paradoxically, increased nuclear … -1c
(SREBP-1c) results in lipogenesis in the liver, through induction of LXR-α (225). In this …
(SREBP-1c) results in lipogenesis in the liver, through induction of LXR-α (225). In this …
Development and uses of in vitro hepatic models in toxicology studies
NJ Coltman - 2022 - etheses.bham.ac.uk
… study of liver biology are one of either in vivo murine origin or in vitro cell culture models; …
in hepatic lysosomes which can progress to phospholipidosis - steatosis and eventual …
in hepatic lysosomes which can progress to phospholipidosis - steatosis and eventual …
Three-dimensional liver models: State of the art and their application for hepatotoxicity evaluation
X Zhang, T Jiang, D Chen, Q Wang… - Critical Reviews in …, 2020 - Taylor & Francis
… More efforts were made in our lab to form mouse hepatocyte … with classical hepatotoxicants
such as amiodarone, bosentan, … , phospholipidosis (PLD) is another hepatic disorder with …
such as amiodarone, bosentan, … , phospholipidosis (PLD) is another hepatic disorder with …
High-content screening for the detection of drug-induced oxidative stress in liver cells
MT Donato, L Tolosa - Antioxidants, 2021 - mdpi.com
… Mitochondrial dysfunction induced by drugs, or more frequently by their reactive
metabolites, contributes to increased ROS formation and oxidative damage to liver cells. …
metabolites, contributes to increased ROS formation and oxidative damage to liver cells. …
Metabophore-mediated retro-metabolic ('MeMeReMe') approach in drug design
S Balaji - Drug Discovery Today, 2023 - Elsevier
… For instance, the N-oxide of tamoxifen is formed in the liver due to increased CYP3A4 … -a-go-go
related gene (hERG) potassium channel or that induce phospholipidosis (PLD). As the …
related gene (hERG) potassium channel or that induce phospholipidosis (PLD). As the …
Untargeted metabolomic analysis of the effects and mechanism of nuciferine treatment on rats with nonalcoholic fatty liver disease
H Cui, Y Li, M Cao, J Liao, X Liu, J Miao, H Fu… - Frontiers in …, 2020 - frontiersin.org
… Consistent with previous studies (Jiang et al., 2016), our results showed that the body weight,
lipid contents, and liver enzymes in the serum of animals were increased in rats receiving …
lipid contents, and liver enzymes in the serum of animals were increased in rats receiving …
Mechanism-based integrated assay systems for the prediction of drug-induced liver injury
M Kawaguchi, T Nukaga, S Sekine, A Takemura… - Toxicology and Applied …, 2020 - Elsevier
… Liver produces physiological energy and degrades and excretes exogenous compounds.
It has a much higher mitochondrial density than most other organs. Liver can also synthesize …
It has a much higher mitochondrial density than most other organs. Liver can also synthesize …
[HTML][HTML] Can oxysterols work in anti-glioblastoma therapy? Model studies complemented with biological experiments
A Wnętrzak, A Kubisiak, A Filiczkowska… - … et Biophysica Acta (BBA …, 2021 - Elsevier
… apoptosis and phospholipidosis are related and may share … metabolism include inhibition
of Liver X receptors (LXR) with … reviled an increase in phospholipidosis after incubation with 7…
of Liver X receptors (LXR) with … reviled an increase in phospholipidosis after incubation with 7…
Loss of splicing factor SRSF3 impairs lipophagy through ubiquitination and degradation of Syntaxin17 in hepatocytes
Y Li, T Wang, Q Liao, X Luo, X Wang, S Zeng… - Journal of Lipid …, 2023 - ASBMB
… We found that ubiquitination of STX17 was increased and upregulation of seven in absentia
… liver disease, indicating a novel potential therapeutic target for fatty liver disease treatment. …
… liver disease, indicating a novel potential therapeutic target for fatty liver disease treatment. …
[HTML][HTML] The effect of hydroxychloroquine on cholesterol metabolism in statin treated patients after myocardial infarction
L Ulander, P Simonen, H Tolppanen, O Hartman… - Atherosclerosis …, 2023 - Elsevier
… amphiphilic drugs like, eg, amiodarone. These drugs have a … a storage disorder called
phospholipidosis. Furthermore, the … (prolonged QT-time or increase of liver enzymes), medical …
phospholipidosis. Furthermore, the … (prolonged QT-time or increase of liver enzymes), medical …